JP5918992B2 - Bath agent composition - Google Patents
Bath agent composition Download PDFInfo
- Publication number
- JP5918992B2 JP5918992B2 JP2011281341A JP2011281341A JP5918992B2 JP 5918992 B2 JP5918992 B2 JP 5918992B2 JP 2011281341 A JP2011281341 A JP 2011281341A JP 2011281341 A JP2011281341 A JP 2011281341A JP 5918992 B2 JP5918992 B2 JP 5918992B2
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- component
- agent composition
- bath agent
- bath
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 41
- 239000013040 bath agent Substances 0.000 title claims description 34
- 239000000194 fatty acid Substances 0.000 claims description 41
- -1 fatty acid ester Chemical class 0.000 claims description 38
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 37
- 229930195729 fatty acid Natural products 0.000 claims description 37
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 32
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 239000001569 carbon dioxide Substances 0.000 claims description 16
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 16
- 150000004665 fatty acids Chemical group 0.000 claims description 15
- 239000002736 nonionic surfactant Substances 0.000 claims description 15
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 239000003232 water-soluble binding agent Substances 0.000 claims description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000004484 Briquette Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 230000000694 effects Effects 0.000 description 11
- 239000007789 gas Substances 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 238000000465 moulding Methods 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 239000003788 bath preparation Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000003287 bathing Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000011087 fumaric acid Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229940100608 glycol distearate Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- PZQBWGFCGIRLBB-NJYHNNHUSA-N [(2r)-2-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O PZQBWGFCGIRLBB-NJYHNNHUSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical compound CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、浴用剤組成物に関する。 The present invention relates to a bath agent composition.
従来より、炭酸ガス発生物を配合した入浴剤は、血行促進効果に優れていることが知られている(例えば、特許文献1参照)。こうした入浴剤において、十分な温まり効果をも付与すべく、これまでにも種々の検討がなされている。 Conventionally, it is known that the bath agent which mix | blended the carbon dioxide generator is excellent in the blood circulation promotion effect (for example, refer patent document 1). In such bathing agents, various studies have been made so far in order to impart a sufficient warming effect.
例えば、特許文献2には、炭酸ガス発生物と油性成分とを組み合わせ、油性成分に炭酸ガスを溶解させた入浴剤組成物が提案されており、特許文献3には、炭酸ガスと脂肪酸、脂肪酸グリセリド、非イオン活性剤を組み合わせた入浴剤組成物が提案されている。 For example, Patent Document 2 proposes a bath agent composition in which a carbon dioxide generator and an oil component are combined and carbon dioxide is dissolved in the oil component. Patent Document 3 discloses carbon dioxide, a fatty acid, and a fatty acid. Bath salt compositions combining glycerides and nonionic active agents have been proposed.
しかしながら、これらの入浴剤であると、配合する油性成分や界面活性剤の量によっては、入浴剤の成型時に染み出し等が発生して外観が損なわれたり、浴水面での浮遊物等が増大したりするおそれがあるだけでなく、油浮きが生じたりするおそれもあり、十分な温まり感との両立は必ずしも容易ではない。 However, with these bath additives, depending on the amount of oily components and surfactants to be blended, seepage may occur during the molding of the bath agent, and the appearance may be impaired, or floating substances on the bath surface may increase. In addition, there is a risk that oil floating may occur, and coexistence with a sufficient warming feeling is not always easy.
したがって、本発明の課題は、浴中から浴後にわたって高い温まり感をもたらすとともに、良好な保存安定性を有し、かつ浴水面での浮遊物等をも抑制し得る浴用剤組成物を提供することにある。 Accordingly, an object of the present invention is to provide a bath preparation composition that provides a high warm feeling from the inside of the bath to after the bath, has good storage stability, and can also suppress floating substances on the bath water surface. It is in.
そこで本発明者らは、種々検討してきたところ、炭酸ガス発生物に特定の界面活性剤を特定の量比で併用することにより、十分な温まり感と浴水面での浮遊物等の抑制とを両立できることを見出し、本発明を完成させるに至った。 Therefore, the present inventors have made various studies, and by using a specific surfactant in combination with a specific amount ratio to the carbon dioxide gas generator, sufficient warmth and suppression of suspended matters on the surface of the bath water can be achieved. The inventors have found that both can be achieved, and have completed the present invention.
すなわち、本発明は、次の成分(A)、(B)及び(C):
(A)炭酸ガス発生物、
(B)ポリエチレングリコール脂肪酸エステル及びポリオキシエチレン硬化ヒマシ油から選ばれる1種又は2種以上の非イオン界面活性剤 1〜15質量%、及び
(C)ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル及びグリセリン脂肪酸エステルから選ばれる1種又は2種以上の非イオン界面活性剤
を含有し、成分(C)と成分(B)の質量比((B)/(C))が4〜45である浴用剤組成物を提供するものである。
That is, the present invention includes the following components (A), (B) and (C):
(A) Carbon dioxide generator,
(B) 1 to 15% by mass of one or more nonionic surfactants selected from polyethylene glycol fatty acid ester and polyoxyethylene hydrogenated castor oil, and (C) sorbitan fatty acid ester, propylene glycol fatty acid ester and glycerin fatty acid A bath agent composition containing one or more nonionic surfactants selected from esters and having a mass ratio of component (C) to component (B) ((B) / (C)) of 4 to 45 It provides things.
本発明の浴用剤組成物は、保存安定性に優れ、成型時における染み出し等を抑制して良好な外観を呈することができる。加えて、これを用いて入浴すれば、十分に高い温まり感が得られるとともに、浴水面における浮遊物等の発生をも効果的に抑制することが可能である。 The bath agent composition of the present invention is excellent in storage stability, and can exhibit a good appearance by suppressing bleeding and the like during molding. In addition, if bathing is performed using this, it is possible to obtain a sufficiently high feeling of warming and to effectively suppress the occurrence of suspended matters on the surface of the bath water.
以下、本発明について詳細に説明する。
本発明の浴用剤組成物は、炭酸ガス発生物(A)を含有する。成分(A)の炭酸ガス発生物としては、本発明の浴用剤組成物を浴水に投入したときに炭酸ガスを発生するものであればよいが、酸と炭酸塩とを組み合わせたものが好ましい。酸としては、有機酸及び無機酸のいずれも使用できるが、なかでも水溶性で固体のものが好ましく、有機酸がより好ましい。有機酸としては、例えば、コハク酸、フマル酸、リンゴ酸、アジピン酸、酒石酸、安息香酸、クエン酸、ピロリドンカルボン酸、サリチル酸、マレイン酸、フタル酸、グルタル酸、シュウ酸等が挙げられ、これらを1種又は2種以上組み合わせて用いることができる。なかでも、保存安定性の点から、コハク酸、フマル酸、リンゴ酸、アジピン酸、酒石酸、安息香酸、クエン酸、ピロリドンカルボン酸、サリチル酸が好ましく、フマル酸がより好ましい。
Hereinafter, the present invention will be described in detail.
The bath agent composition of the present invention contains a carbon dioxide gas generator (A). The carbon dioxide gas generation product of component (A) is not particularly limited as long as it generates carbon dioxide gas when the bath agent composition of the present invention is added to the bath water, but is preferably a combination of acid and carbonate. . As the acid, either an organic acid or an inorganic acid can be used. Among them, a water-soluble and solid acid is preferable, and an organic acid is more preferable. Examples of the organic acid include succinic acid, fumaric acid, malic acid, adipic acid, tartaric acid, benzoic acid, citric acid, pyrrolidone carboxylic acid, salicylic acid, maleic acid, phthalic acid, glutaric acid, oxalic acid, and the like. Can be used singly or in combination of two or more. Among these, succinic acid, fumaric acid, malic acid, adipic acid, tartaric acid, benzoic acid, citric acid, pyrrolidone carboxylic acid, and salicylic acid are preferable, and fumaric acid is more preferable from the viewpoint of storage stability.
無機酸としては、例えば、ホウ酸、メタケイ酸、無機ケイ酸等が挙げられ、これらを1種又は2種以上組み合わせて用いることができる。 Examples of the inorganic acid include boric acid, metasilicic acid, inorganic silicic acid and the like, and these can be used alone or in combination of two or more.
炭酸塩としては、炭酸ナトリウム、炭酸水素ナトリウム、炭酸マグネシウム、炭酸カルシウム、炭酸カリウム等が挙げられ、保存安定性の点から、炭酸ナトリウム、炭酸水素ナトリウムが好ましく、炭酸ナトリウムがより好ましい。これらの炭酸塩は、1種又は2種以上組み合わせて用いることができる。 Examples of the carbonate include sodium carbonate, sodium hydrogen carbonate, magnesium carbonate, calcium carbonate, potassium carbonate and the like. From the viewpoint of storage stability, sodium carbonate and sodium hydrogen carbonate are preferable, and sodium carbonate is more preferable. These carbonates can be used alone or in combination of two or more.
成分(A)の炭酸ガス発生物の含有量は、適度な炭酸ガス発生量を確保する点及び保存安定性の点から、本発明の浴用剤組成物中に40〜95質量%であるのが好ましく、50〜90質量%であるのがより好ましい。
好ましい酸と炭酸塩の含有量比率は、20:80〜90:10であり、より好ましくは40:60〜80:20であり、さらに好ましくは50:50〜70:30である。
The content of the carbon dioxide generation product of component (A) is 40 to 95% by mass in the bath agent composition of the present invention from the viewpoint of securing an appropriate amount of carbon dioxide generation and storage stability. Preferably, it is 50-90 mass%.
The preferred content ratio of acid to carbonate is 20:80 to 90:10, more preferably 40:60 to 80:20, and even more preferably 50:50 to 70:30.
本発明の浴用剤組成物は、ポリエチレングリコール脂肪酸エステル及びポリオキシエチレン硬化ヒマシ油から選ばれる1種又は2種以上の非イオン界面活性剤(B)を含有する。成分(B)の非イオン界面活性剤は、本発明の浴用剤組成物において炭酸ガスの皮膚への浸透を促進する効果を発揮して十分な温まり感をもたらすことを発明者らは今回初めて知見した。また、後述するように成分(C)の非イオン界面活性剤とも相まって、成分(C)と成分(B)の質量比((B)/(C))が4〜45であることにより、炭酸ガスの皮膚への浸透を著しく高めることで十分な温まり感を発揮しつつ良好な保存安定性と浴水面における浮遊物等の発生を効果的に抑制することができる。 The bath agent composition of the present invention contains one or more nonionic surfactants (B) selected from polyethylene glycol fatty acid esters and polyoxyethylene hydrogenated castor oil. The present inventors have discovered for the first time that the nonionic surfactant of component (B) exhibits the effect of promoting the penetration of carbon dioxide into the skin in the bath preparation composition of the present invention and brings about a sufficiently warm feeling. did. Further, as described later, in combination with the nonionic surfactant of component (C), the mass ratio ((B) / (C)) of component (C) to component (B) is 4 to 45, so that By significantly increasing the penetration of gas into the skin, it is possible to effectively suppress the occurrence of suspended matter or the like on the surface of the bath water while exhibiting a sufficient warming sensation.
ポリエチレングリコール脂肪酸エステルの脂肪酸残基としては、炭素数4〜24のものが好ましく、なかでも炭素数12〜18のものがより好ましく、さらにステアリン酸、オレイン酸等の炭素数18のものがよりいっそう好ましく、ステアリン酸がまたさらに好ましい。かかるポリエチレングリコール脂肪酸としては、例えば、モノステアリン酸ポリエチレングリコール、ジステアリン酸ポリエチレングリコール等が挙げられ、エチレンオキサイドの平均付加モル数が2〜400、好ましくは100〜300のものが挙げられる。具体的には、例えば、モノステアリン酸ポリエチレングリコール(140E.O)、モノステアリン酸ポリエチレングリコール(250E.O)、ジステアリン酸ポリエチレングリコール(140E.O)が挙げられる。なお、カッコ内の数字はエチレンオキサイドの付加モル数を表す(以下、同様)。 The fatty acid residue of the polyethylene glycol fatty acid ester is preferably one having 4 to 24 carbon atoms, more preferably one having 12 to 18 carbon atoms, and even more one having 18 carbon atoms such as stearic acid and oleic acid. Preferably stearic acid is even more preferred. Examples of the polyethylene glycol fatty acid include polyethylene glycol monostearate, polyethylene glycol distearate, and the like, and those having an average added mole number of ethylene oxide of 2 to 400, preferably 100 to 300 are mentioned. Specific examples include polyethylene glycol monostearate (140 EO), polyethylene glycol monostearate (250 EO), and polyethylene glycol distearate (140 EO). The numbers in parentheses represent the number of moles of ethylene oxide added (hereinafter the same).
ポリオキシエチレン硬化ヒマシ油としては、例えば、エチレンオキサイドの平均付加モル数が5〜100、好ましくは20〜80のものが挙げられる。具体的には、例えば、ポリオキシエチレン硬化ヒマシ油(40E.O)、ポリオキシエチレン硬化ヒマシ油(60E.O)が挙げられる。 Examples of the polyoxyethylene hydrogenated castor oil include those having an average added mole number of ethylene oxide of 5 to 100, preferably 20 to 80. Specific examples include polyoxyethylene hydrogenated castor oil (40E.O) and polyoxyethylene hydrogenated castor oil (60E.O).
成分(B)の非イオン界面活性剤は、本発明の浴用剤組成物中に均一に分散させる観点、及び後述する成分(C)との相乗効果を高める観点から、室温(25℃)で固体又は半固体であるのが好ましい。なお、固体又は半固体であるとは、ペースト状のものをも含む意味であり、かつ流動性を示さず、粘度を測定することができない状態を意味する。 The nonionic surfactant of component (B) is solid at room temperature (25 ° C.) from the viewpoint of uniformly dispersing in the bath agent composition of the present invention and enhancing the synergistic effect with component (C) described later. Or it is preferable that it is a semi-solid. The term “solid or semi-solid” means to include a paste-like material and does not show fluidity and means a state in which the viscosity cannot be measured.
成分(B)の非イオン界面活性剤の合計含有量は、炭酸ガスの皮膚への浸透促進効果の向上を図る観点、及び肌の感触の低下を抑制する観点から、1〜15質量%であり、2〜10質量%であるのが好ましく、3〜8質量%であるのがより好ましい。 The total content of the nonionic surfactant of the component (B) is 1 to 15% by mass from the viewpoint of improving the effect of promoting the penetration of carbon dioxide gas into the skin and suppressing the reduction of skin feel. It is preferable that it is 2-10 mass%, and it is more preferable that it is 3-8 mass%.
本発明の浴用剤組成物は、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル及びグリセリン脂肪酸エステルから選ばれる1種又は2種以上の非イオン界面活性剤(C)を含有する。成分(C)の非イオン界面活性剤は、本発明の浴用剤組成物において、成分(B)による炭酸ガスの皮膚への浸透の促進効果を阻害することなく、浴水面における浮遊物等の発生を効果的に抑制することができ、また成型時における染み出し等を防止することもできる。 The bath agent composition of the present invention contains one or more nonionic surfactants (C) selected from sorbitan fatty acid esters, propylene glycol fatty acid esters and glycerin fatty acid esters. Component (C), a nonionic surfactant, does not inhibit the effect of promoting penetration of carbon dioxide gas into the skin by component (B) in the bath preparation composition of the present invention. Can be effectively suppressed, and bleeding or the like during molding can be prevented.
ソルビタン脂肪酸エステルの脂肪酸残基としては、炭素数4〜24のものが好ましく、なかでも炭素数12〜18のものがより好ましく、具体的には、例えば、ステアリン酸、オレイン酸が好ましく、ステアリン酸がより好ましい。かかるソルビタン脂肪酸エステルとしては、モノ脂肪酸ソルビタン、ジ脂肪酸ソルビタン、トリ脂肪酸ソルビタン、セスキ脂肪酸ソルビタンのいずれであってもよいが、モノ脂肪酸ソルビタンが好ましい。具体的には、例えば、モノステアリン酸ソルビタン、モノオレイン酸ソルビタン、ジステアリン酸ソルビタン、トリステアリン酸ソルビタン、トリオレイン酸ソルビタン、セスキステアリン酸ソルビタン、セスキオレイン酸ソルビタンが挙げられる。なかでも、モノステアリン酸ソルビタンが好ましい。 The fatty acid residue of the sorbitan fatty acid ester is preferably one having 4 to 24 carbon atoms, more preferably one having 12 to 18 carbon atoms. Specifically, for example, stearic acid and oleic acid are preferred, and stearic acid is preferred. Is more preferable. The sorbitan fatty acid ester may be any of mono fatty acid sorbitan, di fatty acid sorbitan, tri fatty acid sorbitan, and sesqui fatty acid sorbitan, but mono fatty acid sorbitan is preferred. Specific examples include sorbitan monostearate, sorbitan monooleate, sorbitan distearate, sorbitan tristearate, sorbitan trioleate, sorbitan sesquistearate, and sorbitan sesquioleate. Of these, sorbitan monostearate is preferable.
プロピレングリコール脂肪酸エステルの脂肪酸残基としては、炭素数4〜24のものが好ましく、なかでも炭素数12〜18のものがより好ましく、具体的には、例えば、ステアリン酸、オレイン酸が好ましく、ステアリン酸がより好ましい。かかるプロピレングリコール脂肪酸エステルとしては、モノ脂肪酸プロピレングリコール、ジ脂肪酸プロピレングリコール、トリ脂肪酸プロピレングリコールのいずれであってもよいが、モノ脂肪酸プロピレングリコールが好ましく、具体的には、例えば、モノステアリン酸プロピレングリコールが挙げられる。 The fatty acid residue of the propylene glycol fatty acid ester is preferably one having 4 to 24 carbon atoms, more preferably one having 12 to 18 carbon atoms, specifically, for example, stearic acid or oleic acid, Acid is more preferred. The propylene glycol fatty acid ester may be any of mono-fatty acid propylene glycol, di-fatty acid propylene glycol, and tri-fatty acid propylene glycol. Mono-fatty acid propylene glycol is preferred, and specific examples thereof include propylene glycol monostearate. Is mentioned.
グリセリン脂肪酸エステルの脂肪酸残基としては、炭素数4〜24のものが好ましく、なかでも炭素数8〜18のものがより好ましく、具体的には、例えば、ステアリン酸、オレイン酸が好ましく、ステアリン酸がより好ましい。かかるグリセリン脂肪酸エステルとしては、モノグリセリン脂肪酸エステル、ジグリセリン脂肪酸エステル、トリグリセリン脂肪酸エステルのいずれであってもよいが、モノグリセリン脂肪酸エステルが好ましく、具体的には、例えば、モノステアリン酸グリセリンが挙げられる。 The fatty acid residue of the glycerin fatty acid ester is preferably one having 4 to 24 carbon atoms, more preferably one having 8 to 18 carbon atoms. Specifically, for example, stearic acid and oleic acid are preferred, and stearic acid is preferred. Is more preferable. Such glycerin fatty acid ester may be any of monoglycerin fatty acid ester, diglycerin fatty acid ester, and triglycerin fatty acid ester, but monoglycerin fatty acid ester is preferable, and specific examples thereof include glyceryl monostearate. It is done.
成分(C)の非イオン界面活性剤の合計含有量は、浴水面における浮遊物等を抑制する観点、及び肌の感触の低下を抑制する観点から、0.02〜15質量%であるのが好ましく、0.1〜1.0質量%であるのがより好ましい。 The total content of the nonionic surfactant of the component (C) is 0.02 to 15% by mass from the viewpoint of suppressing suspended matters and the like on the surface of the bath water, and from the viewpoint of suppressing a decrease in skin feel. Preferably, it is 0.1-1.0 mass%.
本発明の浴用剤組成物において、成分(C)と成分(B)の質量比((B)/(C))は、浴水面での浮遊物等抑制効果の向上を図る観点、及び肌の感触の低下を抑制する観点から、4〜45であり、5〜20が好ましく、5〜15がより好ましい。 In the bath agent composition of the present invention, the mass ratio of the component (C) to the component (B) ((B) / (C)) is intended to improve the effect of suppressing suspended matters on the surface of the bath water, and From a viewpoint of suppressing the fall of a touch, it is 4-45, 5-20 are preferable and 5-15 are more preferable.
なお、本発明の浴用剤組成物には、本発明の効果に影響をもたらさない程度であれば、さらに成分(B)及び成分(C)以外の非イオン界面活性剤を含有してもよい。本発明の浴用剤組成物中における、成分(B)及び成分(C)以外の非イオン界面活性剤の含有量は、5質量%以下であるのが好ましく、1質量%以下であるのがより好ましく、0.8質量%以下であるのがさらに好ましく、0.4質量%以下であるのがまたさらに好ましく、またさらに実質的に含有しないことが好ましい。 The bath agent composition of the present invention may further contain a nonionic surfactant other than the component (B) and the component (C) as long as the effect of the present invention is not affected. In the bath agent composition of the present invention, the content of the nonionic surfactant other than the component (B) and the component (C) is preferably 5% by mass or less, and more preferably 1% by mass or less. Preferably, the content is 0.8% by mass or less, more preferably 0.4% by mass or less, and further preferably not substantially contained.
本発明の浴用剤組成物は、さらに上記成分以外の成分として、油性成分を含有してもよいが、含有しなくてもよい。本発明の浴用剤組成物であれば、油性成分を含有せずとも、十分な温まり感と浴水面での浮遊物等抑制との両立を図りつつ良好な肌感触をもたらすことができる。かかる油性成分としては、例えば、オクタン酸セチル、イソステアリン酸イソステアリル、イソオクタン酸セチル、乳酸ミリスチル、乳酸セチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、アジピン酸イソプロピル等の脂肪酸エステル類;天然油脂や天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリド、2−エチルヘキサン酸グリセリド等のグリセリド類;流動パラフィン、ワセリン、パラフィン、マイクロクリスタリンワックス等の炭化水素油;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸等の高級脂肪酸類;ラウリルアルコール、セチルアルコール、ステアリルアルコール等の高級アルコール類;精油やシリコーン油類が挙げられる。かかる油性成分の含有量は、浴水面の状態および保存安定性の観点から、本発明の浴用剤組成物中に10質量%以下であるのが好ましく、5質量%以下であるのがより好ましく、1質量%以下であるのがさらに好ましく、0.8質量%以下であるのがさらに好ましく、0.4質量%以下であるのがさらに好ましく、さらにまた実質的に含有しないことが好ましい。 The bath agent composition of the present invention may further contain an oily component as a component other than the above components, but may not contain it. The bath agent composition of the present invention can provide a good skin feel while achieving both a sufficient warming feeling and suppression of suspended matters on the surface of the bath water without containing an oil component. Examples of the oil component include fatty acid esters such as cetyl octanoate, isostearyl isostearate, cetyl isooctanoate, myristyl lactate, cetyl lactate, isopropyl myristate, isopropyl palmitate, and isopropyl adipate; Hardened oil obtained by hydrogenation and glycerides such as myristic acid glyceride and 2-ethylhexanoic acid glyceride; hydrocarbon oils such as liquid paraffin, petrolatum, paraffin and microcrystalline wax; lauric acid, myristic acid, palmitic acid, stearin Higher fatty acids such as acids; higher alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol; essential oils and silicone oils. The content of the oily component is preferably 10% by mass or less, more preferably 5% by mass or less, in the bath agent composition of the present invention, from the viewpoint of the state of the bath water surface and storage stability. The content is more preferably 1% by mass or less, further preferably 0.8% by mass or less, further preferably 0.4% by mass or less, and further preferably substantially not contained.
本発明の浴用剤組成物は、さらに成分(D)として、水溶性バインダーを含有してもよい。水溶性バインダーの含有量は、保存安定性に優れ、成型時における染み出し等を抑制して良好な外観を呈することができる観点、及び肌の感触の低下を抑制する観点から、本発明の浴用剤組成物中に1〜20質量%であるのが好ましく、さらに3〜15質量%であるのがより好ましい。水溶性バインダー(D)は熱可塑性であり、水溶液でないことが好ましい。このような水溶性バインダー(D)としては、ポリエチレングリコール、ポリプロピレングリコール、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンフェノールエーテルが好ましく、ポリエチレングリコール、ポリプロピレングリコールがさらに好ましい。また、水溶性バインダーの数平均分子量は、製剤化の観点から、ポリスチレンを標準としたGPC法で4000〜20000が好ましく、6000〜13000がより好ましく、7000〜9000がさらに好ましい。水溶性バインダーとしてポリエチレングリコールを測定する場合には、溶媒として水/エタノールを用いる。また、これらの水溶性バインダーを用いる場合には、数平均分子量の異なる水溶性バインダーを2種類以上組み合わせて用いてもよい。 The bath agent composition of the present invention may further contain a water-soluble binder as component (D). The content of the water-soluble binder is excellent in storage stability, from the viewpoint of suppressing exudation during molding and exhibiting a good appearance, and from the viewpoint of suppressing a decrease in skin feel, for the bath of the present invention. It is preferable that it is 1-20 mass% in an agent composition, and it is more preferable that it is 3-15 mass%. The water-soluble binder (D) is thermoplastic and preferably not an aqueous solution. As such a water-soluble binder (D), polyethylene glycol, polypropylene glycol, polyoxyethylene alkyl ether, and polyoxyethylene phenol ether are preferable, and polyethylene glycol and polypropylene glycol are more preferable. In addition, the number average molecular weight of the water-soluble binder is preferably 4000 to 20000, more preferably 6000 to 13000, and further preferably 7000 to 9000 by GPC method using polystyrene as a standard from the viewpoint of formulation. When measuring polyethylene glycol as a water-soluble binder, water / ethanol is used as a solvent. When these water-soluble binders are used, two or more water-soluble binders having different number average molecular weights may be used in combination.
本発明の浴用剤組成物は、保存安定性に優れ、成型時における染み出し等を抑制して良好な外観を呈することができる観点、浴水面での浮遊物等抑制効果の向上を図る観点から、さらにケイ酸カルシウム、ブドウ糖等の賦形剤を含有してもよい。 The bath agent composition of the present invention is excellent in storage stability, from the viewpoint of suppressing exudation at the time of molding and exhibiting a good appearance, from the viewpoint of improving the effect of suppressing floating substances on the bath water surface. Furthermore, excipients such as calcium silicate and glucose may be contained.
本発明の浴用剤組成物には、その他上記成分以外の成分として、通常浴用剤に用いられる成分を適宜含有させてもよい。かかる成分としては、例えば、塩化カリウム、塩化ナトリウム、硫酸ナトリウム、硫酸マグネシウム、硝酸カリウム、硝酸ナトリウム、ポリリン酸ナトリウム、塩化アンモニウム、硫酸鉄、リン酸ナトリウム、チオ硫酸ナトリウム等の、上記成分(A)に用いられ得る炭酸塩以外の無機塩、カチオン化セルロース等の上記成分(D)以外の水溶性高分子、エタノール、ステアリルアルコール、イソプロピルアルコール、セチルアルコール、ヘキサデシルアルコール等のアルコール、生薬等の薬効成分、色素、香料等が挙げられる。 In the bath agent composition of the present invention, as a component other than the above-described components, components usually used for a bath agent may be appropriately contained. Examples of such components include the above component (A) such as potassium chloride, sodium chloride, sodium sulfate, magnesium sulfate, potassium nitrate, sodium nitrate, sodium polyphosphate, ammonium chloride, iron sulfate, sodium phosphate, and sodium thiosulfate. Inorganic salts other than carbonates that can be used, water-soluble polymers other than the above component (D) such as cationized cellulose, alcohols such as ethanol, stearyl alcohol, isopropyl alcohol, cetyl alcohol, hexadecyl alcohol, and medicinal ingredients such as herbal medicines , Pigments, fragrances and the like.
本発明の浴用剤組成物は、押出造粒等の圧縮造粒方法や、プレス打錠機やブリケットマシーンを用いた圧縮成形法等の常法に従って製造することができ、その形態は粉末、顆粒、粒状、ブリケット錠、錠剤等のいずれであってもよく、また成分の一部を予め造粒あるいは成型してその余の成分と混合した後に成形した形態であってもよい。本発明の浴用剤組成物の1回あたりの使用量(質量)は、浴水150Lあたり20〜200gが好ましく、30〜100gがより好ましい。これにより、適度な炭酸ガス発生量を確保でき、浴中から浴後にわたって肌に良好な感触を付与することができる。 The bath agent composition of the present invention can be produced according to a conventional method such as a compression granulation method such as extrusion granulation, a compression molding method using a press tableting machine or a briquette machine, and the form thereof is powder, granule , Granular, briquette tablet, tablet and the like, or a form obtained by granulating or molding a part of the components in advance and mixing with the remaining components. 20-200g per 150L of bath water is preferable, and, as for the usage-amount (mass) per time of the bath agent composition of this invention, 30-100g is more preferable. Thereby, an appropriate amount of generated carbon dioxide gas can be ensured, and a good feel can be imparted to the skin from after the bath to after the bath.
以下、本発明について、実施例に基づき具体的に説明する。なお、表中に特に示さない限り、各成分の含有量は質量%を示す。 Hereinafter, the present invention will be specifically described based on examples. In addition, unless otherwise indicated in a table | surface, content of each component shows the mass%.
[実施例1〜7及び比較例1〜8]
表1〜2に示す組成の浴用剤組成物を錠剤(50g)として調製した。次いで、下記方法にしたがって、温まり感及び浴水面の状態についての評価を行った。これらの結果を表1〜2に示す。
[Examples 1-7 and Comparative Examples 1-8]
The bath agent compositions having the compositions shown in Tables 1 and 2 were prepared as tablets (50 g). Subsequently, according to the following method, the warming feeling and the state of the bath water surface were evaluated. These results are shown in Tables 1-2.
《温まり感の評価》
20〜40歳代のパネラー10名を用いて、各錠剤をそれぞれ150Lのお湯(40℃)に投入し、均一にしたお湯にパネラーを入浴させ、入浴中、入浴後の温まり感を下記の基準で評価し、10名の平均値を評価点とした。
5:温まる
4:やや温まる
3:さら湯と同等
2:やや温まらない
1:温まらない
<Evaluation of warmth>
Using 10 panelists in their 20s to 40s, each tablet is poured into 150 liters of hot water (40 ° C), and the paneler is bathed in uniform hot water. The average value of 10 people was used as the evaluation score.
5: Warm up 4: Warm up slightly 3: Equivalent to hot water 2: Not warm up 1: Not warm up
《浴水面の状態の評価》
各サンプル(50g)をそれぞれ150Lのお湯(40℃)に投入し、均一になるように攪拌した。投入後10分の浴水面の状態を下記の基準で目視評価を行った。
◎:浮遊物等がほとんどなく、透明度の高い浴水面である
○:浮遊物等が少ない
△:浮遊物等がやや多い
×:浮遊物等が多い
<< Evaluation of the state of the bathing water >>
Each sample (50 g) was poured into 150 L of hot water (40 ° C.) and stirred uniformly. The state of the bath water surface for 10 minutes after the addition was visually evaluated according to the following criteria.
◎: There is almost no suspended matter, etc., and the water surface is highly transparent. ○: Less suspended matter, etc. △: Slightly more suspended matter, etc. ×: Many suspended matter, etc.
表1〜2の結果より、比較例1〜8では、十分な温まり効果が得られなかったり、温まり効果は良好であるものの浴水面において浮遊物が確認された。これに対し、実施例1〜7では、いずれも温浴効果及び浴水面の状態ともに良好であった。 From the results of Tables 1 and 2, in Comparative Examples 1 to 8, a sufficient warming effect was not obtained, or suspended matter was confirmed on the surface of the bath water although the warming effect was good. In contrast, in Examples 1 to 7, both the warm bath effect and the state of the bath water surface were good.
[実施例8〜9及び比較例9〜10]
表3に示すように、予め一部の成分を造粒物とし、これとその余の成分とを混合してか粒状浴用剤組成物を調製した。次いで、下記方法にしたがって、保存安定性に影響を及ぼす圧縮時の染み出し及び調製直後の外観についての評価を行った。これらの結果を表3に示す。
[Examples 8 to 9 and Comparative Examples 9 to 10]
As shown in Table 3, a granular bath preparation composition was prepared by mixing a part of the components in advance with a granulated product and mixing this with the remaining components. Subsequently, according to the following method, the exudation at the time of compression affecting storage stability and the appearance immediately after preparation were evaluated. These results are shown in Table 3.
《圧縮時の染み出し》
打錠セル内に打錠セルの大きさに切り取ったNo.5Cの定量濾紙を2枚重ねた上に、30℃に保温した造粒物32.8gをいれ、設定10MPaの成形圧で30秒間圧縮した。圧縮後、造粒物に直接接しない側の濾紙の重量を測定し、試験前の濾紙の重量を差し引き、染み出し量(mg)とした。
<Breaking out during compression>
In the tableting cell, two No. 5C quantitative filter papers cut to the size of the tableting cell were stacked, and 32.8 g of the granulated product kept at 30 ° C. was put in, and the molding pressure of 10 MPa was set for 30 seconds. Compressed. After compression, the weight of the filter paper on the side not in direct contact with the granulated material was measured, and the weight of the filter paper before the test was subtracted to obtain the amount of seepage (mg).
《入浴剤外観》
調整した入浴剤組成物の配合直後の外観(色素の発色)について、下記の基準にしたがって目視により評価した。
◎:外観が非常に良好である。
○:外観が良好である。
×:外観の悪化を認める。
《Bath additive appearance》
The appearance (color development of the pigment) immediately after blending of the adjusted bath salt composition was visually evaluated according to the following criteria.
A: Appearance is very good.
○: Appearance is good.
X: Deterioration of appearance is recognized.
表3の結果より、成分(B)の非イオン界面活性剤を含有しない比較例9〜10は、実施例8〜9に比べ、染み出し量が多い上に色素の発色も認められ、浴用剤として外観上不適であった。 From the results shown in Table 3, Comparative Examples 9 to 10 which do not contain the nonionic surfactant of component (B) have a larger amount of oozing than the Examples 8 to 9, and color development of the dye is also recognized. As the appearance was unsuitable.
Claims (8)
(A)炭酸ガス発生物、
(B)ポリエチレングリコール脂肪酸エステル及びポリオキシエチレン硬化ヒマシ油から選ばれる1種又は2種以上の非イオン界面活性剤 1〜15質量%、及び
(C)ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル及びグリセリン脂肪酸エステルから選ばれる1種又は2種以上の非イオン界面活性剤
を含有し、成分(C)と成分(B)の質量比((B)/(C))が4〜45であり、かつ
粉末、顆粒、粒状、ブリケット錠、又は錠剤のいずれかである浴用剤組成物。 The following components (A), (B) and (C):
(A) Carbon dioxide generator,
(B) 1 to 15% by mass of one or more nonionic surfactants selected from polyethylene glycol fatty acid ester and polyoxyethylene hydrogenated castor oil, and (C) sorbitan fatty acid ester, propylene glycol fatty acid ester and glycerin fatty acid contain one or more nonionic surfactants selected from the esters, the mass ratio of component (C) and the component (B) ((B) / (C)) is Ri der 4 to 45, and
A bath agent composition which is any of powder, granule, granule, briquette tablet or tablet .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011281341A JP5918992B2 (en) | 2011-12-22 | 2011-12-22 | Bath agent composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011281341A JP5918992B2 (en) | 2011-12-22 | 2011-12-22 | Bath agent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013129635A JP2013129635A (en) | 2013-07-04 |
JP5918992B2 true JP5918992B2 (en) | 2016-05-18 |
Family
ID=48907507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011281341A Active JP5918992B2 (en) | 2011-12-22 | 2011-12-22 | Bath agent composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5918992B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6209079B2 (en) * | 2013-12-20 | 2017-10-04 | 花王株式会社 | Method for producing foamable composition |
US11376401B2 (en) | 2017-04-26 | 2022-07-05 | Acclarent, Inc. | Deflectable guide for medical instrument |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4313230B2 (en) * | 2003-08-26 | 2009-08-12 | 花王株式会社 | Bath agent composition |
JP2006240992A (en) * | 2005-02-28 | 2006-09-14 | Nof Corp | Bath agent |
JP5719532B2 (en) * | 2009-06-16 | 2015-05-20 | 花王株式会社 | Method for producing foamable powder bath composition |
JP5690494B2 (en) * | 2010-03-09 | 2015-03-25 | 花王株式会社 | Solid bath composition |
JP5534874B2 (en) * | 2010-03-12 | 2014-07-02 | 花王株式会社 | Bath agent composition |
-
2011
- 2011-12-22 JP JP2011281341A patent/JP5918992B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013129635A (en) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1536836B1 (en) | Topical emulsion- gel composition comprising diclofenac sodium | |
JP5982664B2 (en) | Effervescent briquette formulation | |
JP6730780B2 (en) | Bath agent composition | |
JP5918992B2 (en) | Bath agent composition | |
JP7217167B2 (en) | Solid bath agent | |
JP4504729B2 (en) | Two-component bath agent | |
JP5826514B2 (en) | Effervescent composition | |
JP6194184B2 (en) | Bath agent composition | |
JP6751179B2 (en) | Bathing method using bath agent composition | |
JP6320602B1 (en) | Cleaning composition. | |
JP6829620B2 (en) | Solid bath salt | |
JP7335758B2 (en) | Effervescent solid bath agent | |
JP2013139411A (en) | Transparent double-layer cleansing cosmetic | |
JP7042106B2 (en) | Effervescent bath composition | |
JP5679752B2 (en) | Bath agent composition | |
JP7502086B2 (en) | Briquette-type bath salts | |
JP5894790B2 (en) | Solid bath agent | |
JP5945133B2 (en) | Bath agent composition | |
JP4641165B2 (en) | Detergent composition for local cleaning equipment | |
JP4348208B2 (en) | Compression mold bath agent | |
JP7150050B2 (en) | skin cleanser composition | |
JP2005060236A (en) | External preparation for skin | |
JP6420538B2 (en) | Bath agent composition | |
JP2018135281A (en) | Bath agent composition | |
JP6975636B2 (en) | Solid bath composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141007 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150818 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151014 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160405 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160411 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5918992 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |